Joel L Johnson

Study design and rationale for the Stabilization of pLaques usIng Darapladib-Thrombolysis in Myocardial Infarction (SOLID-TIMI 52) trial in patients after an acute coronary syndrome.

E. Braunwald, C. Cannon, H. White, 2011, American heart journal.

The effect of darapladib on plasma lipoprotein-associated phospholipase A2 activity and cardiovascular biomarkers in patients with stable coronary heart disease or coronary heart disease risk equivalent: the results of a multicenter, randomized, double-blind, placebo-controlled study.

M. Hanefeld, L. Ruilope, C. Ballantyne, 2008, Journal of the American College of Cardiology.

Peripheral artery disease, biomarkers, and darapladib.

C. Ballantyne, E. Mohler, J. Berger, 2011, American heart journal.

Effect of Darapladib Treatment on Endarterectomy Carotid Plaque Lipoprotein-Associated Phospholipase A2 Activity: A Randomized, Controlled Trial

A. Postle, Salim Janmohamed, Bill Davis, 2014, PloS one.

Study design and rationale for the Stabilization of pLaques usIng Darapladib-Thrombolysis in Myocardial Infarction (SOLID-TIMI 52) trial in patients after an acute coronary syndrome.

E. Braunwald, C. Cannon, H. White, 2011, American heart journal.